Philippe Weigerstorfer's most recent trade in Sonoma Pharmaceuticals Inc. was a trade of 10,000 Stock option (right to buy) done . Disclosure was reported to the exchange on Jan. 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sonoma Pharma Inc | Weigerstorfer Philippe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 10,000 | 20,001 | - | - | Stock option (right to buy) | |
| Sonoma Pharma Inc | Philippe Weigerstorfer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 7,500 | 10,001 | - | - | Stock option (right to buy) |